Frelii's management team has come to terms on a Binding LOI (Letter of Intent) with a NewPath Healthcare Solutions, Inc. The purpose of the LOI is to license Frelii's technology for the Canadian Medical Cannabis Industry. The parameters of the LOI is to use Frelii's technology for precision cannabinoid recommendations, dosing and delivering specific user medical information to the user's doctor/provider. The goal is to make medical cannabis use safer for the patient, inspire confidence in the prescribing physician, and create trust in the industry as a whole.